57 min listen
PT283 – Greg McKee – Psychedelics for Nociplastic Pain
PT283 – Greg McKee – Psychedelics for Nociplastic Pain
ratings:
Length:
72 minutes
Released:
Jan 31, 2022
Format:
Podcast episode
Description
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia. www.psychedelicstoday.com
Released:
Jan 31, 2022
Format:
Podcast episode
Titles in the series (100)
Kyle's Story: In this episode of Psychedelics Today, Joe interviews the co-host of the show, Kyle Buller. As hosts of the show, we thought that it would be fun to dig a little deeper into our own personal narratives to give our listeners an idea of who we... by Psychedelics Today